Back to mobile site

Johnson & Johnson's (JNJ) Wins $1.67B Patent Verdict Versus Abbott Laboratories (ABT)

June 30, 2009 7:20 AM EDT Send to a Friend
Centocor Ortho Biotech Inc., wholly-owned subsidiary of Johnson & Johnson (NYSE: JNJ), announced ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login